Clinical chemistry therapeutic drug monitoring IVDs

Država: Australija

Jezik: engleski

Izvor: Department of Health (Therapeutic Goods Administration)

Dostupno od:

Emergo Asia Pacific Pty Ltd T/a Emergo Australia

Razred:

Class 2

Proizveden od:

Utak Laboratories Inc 25020 Avenue Tibbitts, Valencia, CA, 91355 United States Of America

Područje terapije:

CT860 - Clinical chemistry therapeutic drug monitoring IVDs

Terapijske indikacije:

The UTAK controls are for use as quality control material for measuring the levels of anitepileptic drugs, antifungals, antipsychotics, immunosuppressive agents, pentobarbital, meprobamate, methotrexate, methylmalonic acid and other TDMs in serum, whole blood and urine. They are intended for use on a continuous basis so that a statistical evaluation of testing performance can be obtained.

Status autorizacije:

A

Datum autorizacije:

2014-02-05